Concepedia

Liv Johannessen

LJ

Statistics

Publications

8

Citations

614

H-Index

8

Active since

2011

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Massachusetts General Hospital

Broad Institute

Frederick National Laboratory for Cancer Research

Liv Johannessen is an author at Harvard University specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

2011–2021

8

Publications

8

Discovery and Characterization of SY-1365, a Selective, Covalent Inhibitor of CDK7

Shanhu Hu, Jason Marineau, Nisha Rajagopal et al. · Cancer Research · 2019 · 151 citations

, , +15

Development of Selective Covalent Janus Kinase 3 Inhibitors

Li Tan, Koshi Akahane, Randall McNally et al. · Journal of Medicinal Chemistry · 2015 · 115 citations · Full text

, , +16

Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function <i>in Vivo</i>

Thomas B. Sundberg, Yanke Liang, Huixian Wu et al. · ACS Chemical Biology · 2016 · 86 citations · Full text

, , +17

Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8

John M. Hatcher, Eric S. Wang, Liv Johannessen et al. · ACS Medicinal Chemistry Letters · 2018 · 84 citations · Full text

, , +15

High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site

Tanmay Chavan, Hyunbum Jang, Lyuba Khavrutskii et al. · Biophysical Journal · 2015 · 81 citations · Full text

, , +17

1–5 of 8